<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-07-18</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39021266/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Assessing T-cell receptor clonality by next-generation sequencing in atypical cutaneous lymphoid infiltrates and cutaneous T-cell lymphoma: A scoping review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39021266-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The diagnosis of cutaneous T-cell lymphoma (CTCL) remains challenging. Demonstration of a clonal T-cell population using T-cell receptor (TCR) gene rearrangement studies by next-generation sequencing (NGS) has been explored in several studies. This review summarizes the current literature on NGS-based sequencing methods for the assessment of TCR clonality in the evaluation of atypical cutaneous lymphoid infiltrates and CTCL on behalf of the American Society of Dermatopathology Appropriate &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39021292/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39021292-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Epstein-Barr virus (EBV) infection has long been associated with the development of multiple sclerosis (MS). MS patients have elevated titers of EBV-specific antibodies in serum and show signs of CNS damage only after EBV infection. Regarding CD8+ T-cells, an elevated but ineffective response to EBV was suggested in MS patients, who present with a broader MHC-I-restricted EBV-specific T-cell receptor beta chain (TRB) repertoire compared to controls. It is not known whether this altered &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39021823/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Biomarker-guided detection of acute kidney injury in abdominal aortic surgery: the new and the old</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39021823-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our study suggests that routine parameters like urine osmolality, CysC, SCr and 6 h urine output perform best in predicting postoperative AKI after aortic surgery compared to the new biomarkers (TIMP-2) Ã— (IGFBP7) and suPAR. Combining biomarkers, particularly CysC or SCr with urine output, urine osmolality, may enhance diagnostic accuracy. Further validation in larger cohorts and clinical settings is warranted to establish their clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39022446/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Leisure-Time Physical Activity Participation in Middle-Aged and Older Adults With a Spinal Cord Injury in Australia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39022446-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: LTPA promotion in the SCI population â‰¥45 years focusing on females and non-traumatic injuries is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39022646/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Unraveling glioblastoma diversity: Insights into methylation subtypes and spatial relationships</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39022646-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This study linked molecular diversity and spatial features in glioblastomas using SVR-LSM. Future studies should validate these findings in larger, independent cohorts to confirm the observed &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39022679/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Small nucleolar RNA expression profiles: A potential prognostic biomarker for non-viral Hepatocellular carcinoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39022679-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Hepatocellular carcinoma (HCC) is a challenging cancer with high mortality rates, limited predictability, and a lack of effective prognostic indicators. The relationship between small nucleolar RNAs (snoRNAs) and HCC is poorly understood. Based on the literature data, snoRNA studies were primarily focused on viral-related causes of HCC, such as Hepatitis B or C viruses (HBV or HCV). According to these studies, we selected four snoRNAs (snoRA12, snoRA47, snoRA80E, and snoRD126) for exploration &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39022738/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Outcomes in elderly patients undergoing endovascular thrombectomy in association with premorbid Rankin Scale scores</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39022738-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Both age and pmRS are important in assessing the benefits of EVT. However, prestroke functional status might be more crucial than biological age in determining outcomes following &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023088/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023088-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: To our knowledge, these are the first reported associations between early RV seropositivity and later MS development. This suggests a broadening of the virus hypothesis in MS aetiology, where molecular mimicry between rubella epitopes and human central nervous system molecules could be an attractive possible &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023141/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Catheter-based ablation to improve outcomes in patients with atrial fibrillation and heart failure with preserved ejection fraction: Rationale and design of the CABA-HFPEF-DZHK27 trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023141-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: CABA-HFPEF-DZHK27 will define the role of systematic and early catheter ablation in patients with AF and HFpEF or &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023254/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">The polinton-like supergroup of viruses: evolution, molecular biology, and taxonomy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023254-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    SUMMARYPolintons are 15-20 kb-long self-synthesizing transposons that are widespread in eukaryotic, and in particular protist, genomes. Apart from a transposase and a protein-primed DNA polymerase, polintons encode homologs of major and minor jelly-roll capsid proteins, DNA-packaging ATPases, and proteases involved in capsid maturation of diverse eukaryotic viruses of kingdom Bamfordvirae. Given the conservation of these structural and morphogenetic proteins among polintons, these elements &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023303/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Prospective evaluation of quantitative response parameter in patients with Gastrointestinal Stroma TumorÂ undergoing tyrosine kinase inhibitor therapy-Impact on clinical outcome</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023303-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The purpose of this study was to determine if dual-energy CT (DECT) vital iodine tumor burden (ViTB), a direct assessment of tumor vascularity, allows reliable response assessment in patients with GIST compared to established CT criteria such as RECIST1.1 and modified Choi (mChoi). From 03/2014 to 12/2019, 138 patients (64 years [32-94 years]) with biopsy proven GIST were entered in this prospective, multi-center trial. All patients were treated with tyrosine kinase inhibitors (TKI) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023338/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Reply to Yang and Lu</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023338-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023343/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Retinoic acid generates a beneficial microenvironment for liver progenitor cell activation in acute liver failure</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023343-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: During ALF, RA secreted by activated HSCs promotes LPC activation, a prerequisite for subsequent LPC-mediated liver &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023538/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Factors influencing circuit lifetime in paediatric continuous kidney replacement therapies - results from the EurAKId registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023538-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Anticoagulation modality, dialyser surface, and vascular access site influence MCL. RCA should be considered when choosing first-line anticoagulation for CKRT in children. Further efforts should focus on developing guidelines and clinical practice recommendations for paediatric &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023541/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Comparative Efficacy of Flow Diverter Devices in the Treatment of Carotid Sidewall Intracranial Aneurysms: aÂ Retrospective, Multicenter Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023541-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: All the first-generation devices achieved good clinical outcomes and retreatment rates in treating ICA sidewall aneurysms. Prospective studies are needed to explore the nuanced differences between these devices in the long &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023548/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Palliative neurology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023548-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Palliative medicine represents the holistic multiprofessional treatment of severely and incurably ill people and their relatives, addressing their complex physical, psychological, social and spiritual needs. The central therapeutic goals are the quality of life and alleviation of suffering. In the course of many neurological diseases, high symptom burden, long and variable trajectories and unfavorable prognosis at times create a need for palliative care even at an early stage, which is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023637/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">ERSPC trial-prostate-specific antigen (PSA)-based prostate cancer screening in older men</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023637-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023777/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">[&lt;sup&gt;68&lt;/sup&gt;Ga]Ga-FAPI versus 2-[&lt;sup&gt;18&lt;/sup&gt;F]FDG PET/CT in patients with autoimmune thyroiditis: a case control study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023777-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Patients with AIT show higher thyroid uptake on [^(68)Ga]Ga-FAPI and 2-[^(18)F]FDG PET. Incidental thyroid uptake is another pitfall in the interpretation of [^(68)Ga]Ga-FAPI PET and should prompt a clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023865/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">Armand P, Zinzani PL, Lee HJ, etÂ al. Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma. Blood. 2023;142(10):878-886</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023865-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023866/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">BsAbs before CD19 CAR-T: full speed ahead!</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023866-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023867/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">Treatment of relapsed CLL &#34;in the BAAG&#34;?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023867-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023868/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">Double-hit, double-expressor follicular lymphoma with plasmacytic differentiation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023868-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023869/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">Transplant, MRD, and predicting relapse in AML</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023869-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023870/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">Is rituximab retro in mantle cell lymphoma?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023870-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023871/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">Melnick AF, Mullin C, Lin K, etÂ al. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress. Blood. 2023;142(25):2159-2174</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023871-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023872/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">UnSETtling energy dependence of t(4;14) MM</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023872-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023873/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">Gasdermin D and TMA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023873-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023874/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">Essential thrombocythemia with MPL W515S mutation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023874-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023875/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">van der Straten L, Stege CAM, Kersting S, etÂ al. Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL. Blood. 2023;142(13):1131-1142</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023875-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023876/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">Choosing donors in clinical practice</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023876-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39023877/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240718181718&amp;v=2.18.0.post9&#43;e462414">Alternative donors in severe aplastic anemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39023877-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240718181718-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Oo5jHe7Kj">ç¾å›½å«ç”Ÿå’Œäººç±»æœåŠ¡éƒ¨ï¼ˆDHHSï¼‰åœ¨ä»Šå¤©ä¸Šçº¿çš„NEJMä¸Šå‘è¡¨äº†ä¸€ç¯‡è§‚ç‚¹æ–‡ç« ï¼Œé¢˜ç›®æ˜¯åšå¥½ä¸‹ä¸€æ¬¡å¤§æµè¡Œå‘ç”Ÿçš„å‡†å¤‡ï¼ˆAnticipating the Next Pandemicï¼‰ã€‚è™½ç„¶æ–°å‹å† çŠ¶ç—…æ¯’...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oo5jhe7kj/">
    
    
    
    
    
      
    
    ç¾å›½å«ç”Ÿå’Œäººç±»æœåŠ¡éƒ¨ï¼ˆDHHSï¼‰åœ¨ä»Šå¤©ä¸Šçº¿çš„NEJMä¸Šå‘è¡¨äº†ä¸€ç¯‡è§‚ç‚¹æ–‡ç« ï¼Œé¢˜ç›®æ˜¯åšå¥½ä¸‹ä¸€æ¬¡å¤§æµè¡Œå‘ç”Ÿçš„å‡†å¤‡ï¼ˆAnticipating the Next Pandemicï¼‰ã€‚è™½ç„¶æ–°å‹å† çŠ¶ç—…æ¯’SARS-CoV-2å¤§æµè¡Œä¸­æœ‰è¯¸å¤šæ•™è®­ï¼Œä½†ä¹Ÿæœ‰å¾ˆå¤šç»éªŒï¼Œè¿™é‡Œæœ‰3ç‚¹: 1. é›†ç»“åŠ›é‡åœ¨ä¸åˆ°ä¸€å¹´æ—¶é—´ç ”å‘å‡ºäº†æœ‰æ•ˆæ€§é«˜è¾¾95%çš„SARS-CoV-2ç–«è‹—ï¼›2. å¦‚ä½•åœ¨å…¨çƒèŒƒå›´å†…è¿…é€Ÿå¼€å±•ç–«è‹—æ¥ç§å·¥ä½œã€å¦‚ä½•åˆ†é…ç–«è‹—èµ„æºã€è¿…é€Ÿæ‰©å¤§ç”Ÿäº§ã€æœ‰æ•ˆæŠ•é€’å¹¶æ•™è‚²å…¬ä¼—ç–«è‹—æ¥ç§çš„å·¨å¤§ç›Šå¤„ï¼›3. å¦‚ä½•åœ¨æ”¿åºœä¸ç§è¥æœºæ„é—´å»ºç«‹å¹¿æ³›è€Œæ·±å…¥çš„åˆä½œï¼Œåˆ‡å®æ¨è¿›ç–«è‹—è¿…é€Ÿç ”å‘ï¼ˆæ¯”å¦‚NIHå’ŒModernaï¼‰ï¼Œè¿™ä¹Ÿæ˜¯Dr. Fauciåœ¨æ¥å—STAT News First Opinioné‡‡è®¿æ—¶é‡ç‚¹å¼ºè°ƒçš„ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™ç¯‡æ–‡ç« åŒæ—¶ä»‹ç»äº†DHHS BARDAæŠ•å…¥50äº¿ç¾å…ƒå¼€å‘æ–°ä¸€ä»£ç–«è‹—NextGençš„å·¥ä½œï¼Œæˆ‘ä¸€å¹´å‰æ›¾ç»ä»‹ç»è¿‡ï¼ˆ<!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Oo6nW7Wyj">åœ¨ä¸œè¥¿æµ·å²¸å‡ ä¸ªå¤§åŸå¸‚çš„å¤§pharmaï¼Œä½ èƒ½æ„Ÿè§‰å‘¨å›´å¾ˆå¤šå¾ˆå¤šäººç‰¹åˆ«polishedã€‚åœ¨å¤§å‹å·¥ä½œä¼šè®®ç”šè‡³åœ¨ç”µæ¢¯é‡Œï¼Œå¥½å¤šåŒäº‹æ˜¯è¶…æ¨¡ä¸€æ ·çš„é«˜é¢œå€¼ï¼›è€Œä¸”åœ¨R&amp;Dçš„Då·¥ä½œï¼Œä¸å°‘äººéƒ½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oo6nw7wyj/">
    
    
    
    
    
      
    
    åœ¨ä¸œè¥¿æµ·å²¸å‡ ä¸ªå¤§åŸå¸‚çš„å¤§pharmaï¼Œä½ èƒ½æ„Ÿè§‰å‘¨å›´å¾ˆå¤šå¾ˆå¤šäººç‰¹åˆ«polishedã€‚åœ¨å¤§å‹å·¥ä½œä¼šè®®ç”šè‡³åœ¨ç”µæ¢¯é‡Œï¼Œå¥½å¤šåŒäº‹æ˜¯è¶…æ¨¡ä¸€æ ·çš„é«˜é¢œå€¼ï¼›è€Œä¸”åœ¨R&amp;Dçš„Då·¥ä½œï¼Œä¸å°‘äººéƒ½æ˜¯é‚£å‡ ä¸ªé¡¶çº§ç§ç«‹å­¦æ ¡åŒ»å­¦é™¢æ¯•ä¸šçš„MDç”šè‡³MD-PhDï¼Œä¹‹åè¿›å…¥äº†æœ€å¥½çš„residency programï¼Œä»–ä»¬è¯´è¯æ—¶ä¼šè®©äººè§‰å¾—ä»–ä»¬åœ¨glowingã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->äººäººéƒ½æœ‰snobçš„ä¸€é¢ï¼Œæˆ‘ä¹Ÿæœ‰ï¼Œä½†åˆ°äº†æˆ‘ç°åœ¨è¿™ä¸ªé˜¶æ®µï¼Œæˆ‘ç°åœ¨è¶Šæ¥è¶Šä¸ä¼šä¸ºè¿™äº›äº‹æƒ…æœ‰ä»»ä½•è‡ªå‘æˆ–ä¸é€‚äº†ã€‚æˆ‘æƒ³çš„æ˜¯æˆ‘ä»¬è™½ç„¶ç”Ÿé•¿äºä¸åŒçš„åœ°æ–¹ï¼Œæœ‰ä¸åŒçš„ç§æ—å’Œè‚¤è‰²ï¼Œæ¯•ä¸šäºä¸åŒçš„å­¦æ ¡ï¼Œä½†æˆ‘ä»¬åœ¨ä¸€ä¸ªåœ°æ–¹åšä¸€æ ·çš„å·¥ä½œï¼Œæˆ‘ä»¬çš„ç›®æ ‡ä¹Ÿæ˜¯ä¸€æ ·çš„ã€‚æˆ‘è§‰å¾—æˆ‘ä¼šåšçš„å°±æ˜¯forward lookingï¼›è€Œä¸ä¼šå»æƒ³è‡ªå·±çš„è¿‡å»ç¼ºäº†ä»€ä¹ˆï¼Œæ‰€ä»¥ç°åœ¨å¿…é¡»è¿‡åº¦è¡¥å¿ã€‚åœ¨è¿™ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Oo79E2Ili">è¿‘ä¸€å‘¨çš„æ—¶é—´ï¼ŒPubMedä¸€ç›´å°†1995å¹´7æœˆ1æ—¥çš„Lancetæ–‡ç« ç½®é¡¶ï¼Œä½œä¸ºæ¨èæ–‡ç« ï¼ˆTrending Articlesï¼‰ã€‚æ–‡ç« é¢˜ç›®æ˜¯â€œPrevalence of HIV infection among former commer...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oo79e2ili/">
    
    
    
    
    
      
    
    è¿‘ä¸€å‘¨çš„æ—¶é—´ï¼ŒPubMedä¸€ç›´å°†1995å¹´7æœˆ1æ—¥çš„Lancetæ–‡ç« ç½®é¡¶ï¼Œä½œä¸ºæ¨èæ–‡ç« ï¼ˆTrending Articlesï¼‰ã€‚æ–‡ç« é¢˜ç›®æ˜¯â€œPrevalence of HIV infection among former commercial plasma donors in rural eastern Chinaâ€ã€‚è¿™ç¯‡æ–‡ç« æ˜¯å´å°Šå‹çš„æˆåä½œï¼Œä¹Ÿæ˜¯ä»–åœ¨UCLAçš„åšå£«è¯¾é¢˜ä¹‹ä¸€ã€‚è¿™äº¦æ˜¯ä¸­å›½ä¸€æ¬¡é‡å¤§ç—…æ¯’ç—…æµè¡Œå²çš„ä¸€ä¸ªç¼©å½±ã€‚è¿™ä¸ªäº‹ä»¶æ˜¯90å¹´ä»£ä¸€ä¸ªé‡å¤§çš„å…¬å…±å«ç”Ÿäº‹ä»¶ï¼Œä¸å¹¸çš„æ˜¯åæ¥ä¹Ÿè¢«politicizedäº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™ç¯‡æ–‡ç« è®²äº†1995å¹´å®‰å¾½é˜œé˜³åœ°åŒºä¸€å42å²å¥³æ€§å’Œå¥¹ä¸¤ä¸ªå¥³å„¿è¢«æ£€æµ‹å‡ºHIV-1æŠ—ä½“é˜³æ€§ï¼Œè€Œåå¼•å‡ºäº†è¡€åˆ¶å“æ±¡æŸ“ï¼ˆè¡€æµ†å•é‡‡æ³•ï¼‰å¯¼è‡´çš„HIV-1åœ°åŒºæµè¡Œçš„æƒ…å†µã€‚è¡€åˆ¶å“æ±¡æŸ“å¯¼è‡´HIV-1ä¼ æ’­å…¶å®å¹¶ä¸ç½•è§ï¼Œ1987å¹´æ³•å›½é™†ç»­å‡ºç°è¡€å‹ç—…æ‚£è€…æ„ŸæŸ“HIVçš„æƒ…å†µã€‚90å¹´ä»£ä¸­æœŸï¼Œä¸­å›½å«ç”Ÿéƒ¨é—¨å·²ç»çŸ¥æ™“äº†è¿™ä¸ªæƒ…å†µã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ä»2010å¹´ä¸­å›½ç–¾æ§ä¸­å¿ƒå¼ ç¦æ°ç­‰åšçš„åˆ†å­æµ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Oodn5EYUA">Don&#39;t wanna be an American idiotOne nation controlled by the mediaInformation age of hysteriaIt&#39;s calling out to idiot America- American Idiot [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oodn5eyua/">
    
    
    
    
    
      
    
    Don&rsquo;t wanna be an American idiot<!-- raw HTML omitted -->One nation controlled by the media<!-- raw HTML omitted -->Information age of hysteria<!-- raw HTML omitted -->It&rsquo;s calling out to idiot America<!-- raw HTML omitted -->- American Idiot <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Oo66CjSeo">ä¸€åˆ°æˆéƒ½ä¸œç«™ï¼Œå°±æƒ³èµ·ä¸Šä¸ªæœˆåœ¨ä¼Šæ–¯å¦å¸ƒå°”é«˜é“ç«™çš„æƒ…æ™¯ï¼Œæƒ…ä¸è‡ªç¦ä¸ºæˆ‘ä»¬çš„é«˜é“ç«™[èµ][èµ][èµ] æŸ¥çœ‹å›¾ç‰‡ - è½¬å‘ @ç§è±†å¾—ç“œè°¢ä¸è°¦:&amp;ensp;æŒ‰ç…§å–µçˆ¸åˆ¶å®šçš„åœŸè€³å…¶æ”»ç•¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oo66cjseo/">
    
    
    
    
    
      
    
    ä¸€åˆ°æˆéƒ½ä¸œç«™ï¼Œå°±æƒ³èµ·ä¸Šä¸ªæœˆåœ¨ä¼Šæ–¯å¦å¸ƒå°”é«˜é“ç«™çš„æƒ…æ™¯ï¼Œæƒ…ä¸è‡ªç¦ä¸ºæˆ‘ä»¬çš„é«˜é“ç«™<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[èµ]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/others/h_zan-44ddc70637.png%22">https://h5.sinaimg.cn/m/emoticon/icon/others/h_zan-44ddc70637.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Oo737Bp1S">ä¸‰å¹´å‰å›è€å®¶ï¼Œåƒè¿‡åŠ¨è½¦çš„ç‰›è…©å¥—é¤ï¼Œåˆè´µåˆéš¾åƒï¼Œä¸çŸ¥ç°åœ¨æœ‰æ”¹è¿›å¦ï¼Ÿæˆ‘è·Ÿå¤§å¤šä¹˜å®¢ä¸€æ ·ï¼Œé€‰æ‹©æ³¡é¢ã€‚ é‚å®Â·å¤§è‹±ä¸œç«™ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oo737bp1s/">
    
    
    
    
    
      
    
    ä¸‰å¹´å‰å›è€å®¶ï¼Œåƒè¿‡åŠ¨è½¦çš„ç‰›è…©å¥—é¤ï¼Œåˆè´µåˆéš¾åƒï¼Œä¸çŸ¥ç°åœ¨æœ‰æ”¹è¿›å¦ï¼Ÿæˆ‘è·Ÿå¤§å¤šä¹˜å®¢ä¸€æ ·ï¼Œé€‰æ‹©æ³¡é¢ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->é‚å®Â·å¤§è‹±ä¸œç«™<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/d1840ee6gy1hrs3a43wqgj22bc3344q">https://tvax1.sinaimg.cn/large/d1840ee6gy1hrs3a43wqgj22bc3344q</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Oo8mOvqEy">è¾¾å·è™½ç„¶ä¹Ÿåœ¨ä¸‹é›¨ï¼Œä½†ç©ºæ°”æ¯”æˆéƒ½çƒ­å¾—å¤šã€‚æœ¬æ¥å¯ä»¥åœ¨è¾¾å·ç«™ä¹˜å‡ºç§Ÿè½¦å›å®£æ±‰åŸï¼Œä½†æˆ‘å–œæ¬¢ä¹˜ç©ºé—´å¤§ä¸€ç‚¹çš„è½¦ï¼Œæ‰€ä»¥åå…¬äº¤æ¥å®¢è¿åŒ—ç«™ï¼Œä¹˜ä¸­å·´å›å®£æ±‰åŸã€‚ è¾¾å·Â·è¾¾å·å®¢...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oo8movqey/">
    
    
    
    
    
      
    
    è¾¾å·è™½ç„¶ä¹Ÿåœ¨ä¸‹é›¨ï¼Œä½†ç©ºæ°”æ¯”æˆéƒ½çƒ­å¾—å¤šã€‚æœ¬æ¥å¯ä»¥åœ¨è¾¾å·ç«™ä¹˜å‡ºç§Ÿè½¦å›å®£æ±‰åŸï¼Œä½†æˆ‘å–œæ¬¢ä¹˜ç©ºé—´å¤§ä¸€ç‚¹çš„è½¦ï¼Œæ‰€ä»¥åå…¬äº¤æ¥å®¢è¿åŒ—ç«™ï¼Œä¹˜ä¸­å·´å›å®£æ±‰åŸã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->è¾¾å·Â·è¾¾å·å®¢è¿åŒ—ç«™<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/">https://tvax1.sinaimg.cn/large/</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Oobp23K24">ä¸Šå‘¨ï¼Œæ¯äº²å¶æ„Ÿé£å¯’ï¼Œæµ‘èº«ç–¼ï¼Œæˆ‘å¾®ä¿¡è§†é¢‘è¯´å›å»çœ‹æœ›ä½ ï¼Ÿå¥¹è¯´ä¸ç”¨æ‹…å¿ƒæˆ‘ï¼Œä½ æŠŠå­™å­çœ‹å¥½ï¼ŒæŠŠä½ ä»¬è‡ªå·±ç…§é¡¾å¥½ï¼æˆ‘è¯´å¥½ã€‚æ¯äº²çš„æƒ…å†µå´è¶Šæ¥è¶Šä¸å¥½ï¼Œå‰å‡ å¤©å§åºŠä¸èµ·ï¼Œç”Ÿ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oobp23k24/">
    
    
    
    
    
      
    
    ä¸Šå‘¨ï¼Œæ¯äº²å¶æ„Ÿé£å¯’ï¼Œæµ‘èº«ç–¼ï¼Œæˆ‘å¾®ä¿¡è§†é¢‘è¯´å›å»çœ‹æœ›ä½ ï¼Ÿå¥¹è¯´ä¸ç”¨æ‹…å¿ƒæˆ‘ï¼Œä½ æŠŠå­™å­çœ‹å¥½ï¼ŒæŠŠä½ ä»¬è‡ªå·±ç…§é¡¾å¥½ï¼æˆ‘è¯´å¥½ã€‚æ¯äº²çš„æƒ…å†µå´è¶Šæ¥è¶Šä¸å¥½ï¼Œå‰å‡ å¤©å§åºŠä¸èµ·ï¼Œç”Ÿæ´»ä¸èƒ½è‡ªç†ï¼Œç»å¸¸ä¸€ä¸ªäººè‡ªè¨€è‡ªè¯­ï¼Œè¯´äº›å¹´è½»æ—¶å€™çš„äººä¸äº‹ã€‚æ¯äº²å·²94.5å²ï¼Œç”Ÿè€ç—…æ­»ï¼Œè‡ªç„¶è§„å¾‹ï¼Œæˆ‘æ˜¯æœ‰æ€æƒ³å‡†å¤‡çš„ã€‚ä»Šå¤©ç‰¹åœ°èµ¶å›æ¥ï¼Œå¥¹èººåœ¨åºŠä¸Šï¼Œæœ‰æ°”æ— åŠ›è¯´ï¼Œå„¿å­å‘€ï¼Œç°åœ¨åƒå–æ‹‰æ’’éƒ½è¦äººç…§é¡¾ï¼Œæ´»èµ·å¤ªéº»çƒ¦äº†ï¼Œæˆ‘ä¸æƒ³æ´»äº†ã€‚æˆ‘è¯´äººéƒ½æœ‰è¿™ä¸€å¤©ï¼Œæœ€åéƒ½éœ€è¦äººç…§é¡¾ï¼Œåäººç…§é¡¾ä¹Ÿæ˜¯åº”è¯¥çš„ã€‚å¥¹è¯´æˆ‘æ™šä¸Šç¡ä¸ç€ï¼Œç™½å¤©ä¹Ÿç¡ä¸ç€ï¼Œéš¾å—ã€‚æˆ‘è¯´æˆ‘æ˜å¤©å»ç»™ä½ ä¹°å®‰çœ è¯ï¼Ÿå¥¹æ— è¯­ã€‚æˆ‘è¯´ä½ æ´»åˆ°95å²ï¼Œè¶…è¿‡äº†ä½ çš„æ‰€æœ‰å…„å¼Ÿå§å¦¹ï¼Œå¥¹è¯´è¿˜å·®5ä¸ªæœˆæ‰95å²ã€‚æˆ‘è¯´ä¸€åˆ‡é¡ºå…¶è‡ªç„¶ï¼Œä½ è‡ªå·±ä¸è¦æ€¥ï¼Œæˆ‘ä»¬ä¹Ÿä¸æŒ½ç•™ä½ ï¼Œè®©ä½ æ— ç‰µæ— æŒ‚ï¼Œæ”¾æ”¾å¿ƒå¿ƒå»åˆ°å¦ä¸€ä¸ªä¸–ç•Œï¼Œå¦‚ä½•ï¼Ÿå¥¹è¯´å¥½ã€‚æˆ‘è¯´æˆ‘æœ€è¿‘åˆšå‡ºäº†ä¸€æœ¬ä¹¦ã€Šç§è±†å¾—ç“œé›†ã€‹ï¼Œæœ‰ä¸€ç¯‡æ–‡ç« ã€Šæˆ‘çˆ¸æˆ‘å¦ˆã€‹ï¼Œè®°è½½ä½ ä¸€ç”Ÿçš„å…‰è¾‰äº‹è¿¹ã€‚å¥¹æ²¡ååº”ï¼Œä¹Ÿè®¸å¥¹å¿ƒä¸åœ¨ç„‰ï¼Œå·²åœ¨å¦å¤–ä¸€ä¸ªä¸–ç•Œï¼Ÿ&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/d1840ee6gy1hrslkj3c6lj20xw2301em.jpg%22">https://tvax4.sinaimg.cn/large/d1840ee6gy1hrslkj3c6lj20xw2301em.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Oo8c6fAHV">éŸ©å›½å¤–å¡è¿˜å¤Ÿåˆ†å—</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-oo8c6fahv/">
    
    
    
    
    
      
    
    éŸ©å›½å¤–å¡è¿˜å¤Ÿåˆ†å—  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oo8TytWHx">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.07.17 20:41ã€Œå‘œå“‡å•Šã€å™—å“ˆï½ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oo8tytwhx/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%25E">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oo9O7nYi1">æ—©ä¸Šä¸ƒç‚¹åŠèµ·åºŠå‡ºé—¨æ™šä¸Šä¸ƒç‚¹åŠåˆ°å®¶ä¼‘æ¯æ€ä¹ˆä¸ç®—ä¸Šç­ğŸš¬</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oo9o7nyi1/">
    
    
    
    
    
      
    
    æ—©ä¸Šä¸ƒç‚¹åŠèµ·åºŠå‡ºé—¨<!-- raw HTML omitted -->æ™šä¸Šä¸ƒç‚¹åŠåˆ°å®¶ä¼‘æ¯<!-- raw HTML omitted -->æ€ä¹ˆä¸ç®—ä¸Šç­ğŸš¬  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oo9W68R6X">çœŸæœ‰åŠ²å„¿[æ·¡æ·¡çš„] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oo9w68r6x/">
    
    
    
    
    
      
    
    çœŸæœ‰åŠ²å„¿[æ·¡æ·¡çš„] <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Ooa5a5YTR">éƒ½é•¿å¤§äº†ä¼šåšèŠ‚ç›®æ•ˆæœäº†ğŸ¥¹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ooa5a5ytr/">
    
    
    
    
    
      
    
    éƒ½é•¿å¤§äº†ä¼šåšèŠ‚ç›®æ•ˆæœäº†ğŸ¥¹ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Ooa6DEMGP">åƒç˜ªä»™äºº[äºŒå“ˆ] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ooa6demgp/">
    
    
    
    
    
      
    
    åƒç˜ªä»™äºº<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OobBszsic">æ–°æ­ŒçœŸçš„é‚£ä¹ˆéš¾å¬å—</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oobbszsic/">
    
    
    
    
    
      
    
    æ–°æ­ŒçœŸçš„é‚£ä¹ˆéš¾å¬å—  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OobDvr2P8">å‹¾å¼ - è½¬å‘ @å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡:&amp;ensp;æ–°æ­ŒçœŸçš„é‚£ä¹ˆéš¾å¬å—</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oobdvr2p8/">
    
    
    
    
    
      
    
    å‹¾å¼<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡<!-- raw HTML omitted -->:â€‚æ–°æ­ŒçœŸçš„é‚£ä¹ˆéš¾å¬å— &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OobEcEYKT">æˆ‘è§‰å¾—itâ€˜s the single lifeå·²ç»æ˜¯çƒ‚æ´»äº†ä½†æ˜¯æ²¡æœ‰æƒ³è¿‡è¿˜ä¼šæœ‰ç¬¬äºŒæ¬¡[å‰‘ç½‘3]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oobeceykt/">
    
    
    
    
    
      
    
    æˆ‘è§‰å¾—itâ€˜s the single lifeå·²ç»æ˜¯çƒ‚æ´»äº†<!-- raw HTML omitted -->ä½†æ˜¯æ²¡æœ‰æƒ³è¿‡è¿˜ä¼šæœ‰ç¬¬äºŒæ¬¡[å‰‘ç½‘3]  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OobRLzUsX">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.07.18 14:08ã€Œç©ºéš™æ—¶é—´ã€æ—©ä¸Šå¥½å“‡ã€œä»Šå¤©ä¹Ÿè¦åŠªåŠ›å–½ä»Šå¤©ä¹Ÿå¿˜äº†å¸¦â€œå¦‚æœå¸¦äº†è¿‡æ¥å°±å¥½äº†ã€ã€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oobrlzusx/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26">https://m.weibo.cn/search?containerid=231522type%3D1%26</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OobRP9XU3">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# .ç ç¾ã€‚ç ç¾æ•™ä¼šäº†æˆ‘è¦çœŸè¯šè€Œçº¯ç²¹åœ°å»çˆ±è‡ªå·±ã€çˆ±åˆ«äººã€‚æˆ‘è¿™ä¹ˆå¹¼ç¨šï¼Œå´èƒ½æœ‰ä½ è¿™ä¹ˆå¥½çš„äººæ¥ç†è§£æˆ‘è°¢è°¢...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oobrp9xu3/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containeri">https://m.weibo.cn/search?containeri</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/Oo6Te06Ke">æ£‹æ‰‹æˆ˜é¹° äº‹å®è¯æ˜èˆ°é•¿æ¶¨ä»·ä¸€äº‹ï¼Œæ²¡æœ‰å½±å“åˆ°æˆ‘è¿™ç§è€çš„åŒ…æœˆç”¨æˆ· [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-oo6te06ke/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted --> äº‹å®è¯æ˜èˆ°é•¿æ¶¨ä»·ä¸€äº‹ï¼Œæ²¡æœ‰å½±å“åˆ°æˆ‘è¿™ç§è€çš„åŒ…æœˆç”¨æˆ· <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Oo5y93shI">æŸ¯æ´#å†œå¿ƒæ¯é€‰æ‹”èµ›# æ˜¨æ—¥å›¾é›†å›¾æº:å¼ˆåŸå›´æ£‹ç½‘ é‡ç‹å›´æ£‹ ä¸­å›½å›´æ£‹åä¼š [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oo5y93shi/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/Oo8rYtc62">æŸ¯æ´#é‡ç‹äººæ°”äº‰éœ¸èµ›##èµ›äº‹é¢„å‘Š# ç¬¬12æœŸé‡ç‹äººæ°”äº‰éœ¸èµ› 16è¿›12æ—¶é—´ï¼š7æœˆ19æ—¥ä¸‹åˆä¸€ç‚¹åœ°ç‚¹ï¼šé‡ç‹å›´æ£‹æ½œä¼ vs miracle97ï¼ˆåç›¸å£¹ä¹æ®µï¼‰ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-oo8rytc62/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B%23&amp;amp;extparam=%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B%23&amp;amp;extparam=%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV16b421J7Nm">é™ˆç¿”å…­ç‚¹åŠï¼šé‚£äº›è¢«å¡åœ¨å–‰å’™é‡Œçš„è¯</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv16b421j7nm/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV17E421w7yS">ä»¥çˆ±ä¸ºåçš„PUAï¼Œè¯¥åœæ­¢äº†ï¼ 10ã€æš´èµ°å°äº‹ä»¶ç¬¬ä¸‰å­£ã€‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv17e421w7ys/">
    
    
    
    
    
      
    
    ä¸€æ¡â€œæ¯å¥³åŠé±¼â€çš„è§†é¢‘ï¼Œè½¬å‘é‡åˆ†åˆ†é’Ÿè¶…40ä¸‡ï¼›
ä¸€å¥â€œéƒ½æ˜¯ä¸ºäº†ä½ â€ï¼Œè‹¦éš¾æ•™è‚²è¯„è®ºåŒºæ— æ•°äººçš„å™©æ¢¦â€¦â€¦
è¯šç„¶ï¼Œè¿™ä¸ªä¸–ç•Œä¸Šå¤§å¤šæ•°çš„çˆ¶æ¯éƒ½æœ‰å…¶çš„ä¸æ˜“ï¼Œä½†äººç”Ÿæ‰€æœ‰çš„è‹¦éš¾ï¼Œéƒ½æ˜¯å­©å­é€ æˆçš„å—ï¼Ÿ
æ²¡æœ‰å¿…è¦çš„è‹¦ï¼Œåˆ«ç¡¬åƒï¼
è‡ªæˆ‘ç‰ºç‰²ã€æƒ…æ„Ÿå‹’ç´¢é‚£ä¸€å¥—æ•™è‚²æ–¹å¼ï¼Œè¯¥åœæ­¢äº†ï¼ &mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&mdash;&ndash;Â 
éƒ¨åˆ†ç´ ææ¥è‡ªç½‘ç»œï¼Œå¦‚ä¾µæƒï¼Œè¯·è”ç³»åˆ é™¤<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img src=&ldquo;<a href="http://i2.hdslb.com/b">http://i2.hdslb.com/b</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1A1421t7bz">ã€å¼ æ·è¯´æ³•ã€‘ç¦»å©šå¼„å‡æˆçœŸï¼Œå‡æˆåè®®æœ‰çœŸæ•ˆå—ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1a1421t7bz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1jW421R7Ce">075åŠ å…¥ä¸­å›½èˆªæ¯æˆ˜æ–—ç¾¤ï¼Œä¸­å›½æµ·å†›å¦‚ä½•å¼€å‘ä¸¤æ –æ”»å‡»èˆ°ç”¨é€”ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1jw421r7ce/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1QE4m1R7iL">ã€å¼ æ·è´¢ç»ã€‘çº³æŒ‡æš´è·Œé»„é‡‘æ–°é«˜ï¼Œç¾å›½è¿˜èƒ½ç†¬å¤šä¹…ï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1qe4m1r7il/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1xx4y1s7ar">ã€ç›´æ’­å›æ”¾ã€‘UOS AIä½¿ç”¨æŠ€å·§åˆ†äº«ç›´æ’­å›æ”¾æ¥å•¦ï¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1xx4y1s7ar/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1zf421z72R">ã€å¼ æ·æ‚è°ˆã€‘æ–°èƒ½æºè½¦çš„ä¿é™©è´¹ä¹‹å¤–ï¼Œçœ‹ä½ æŠŠå®‰å…¨çœ‹å¾—æœ‰å¤šé‡ï¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1zf421z72r/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/07/18/1198909021/the-creeping-coup">The Creeping Coup</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-07-18-1198909021-the-creeping-coup/">
    
    
    
    
    
      
    
    Sudan has been at the center of a deadly and brutal war for over a year. It&rsquo;s the site of the world&rsquo;s largest hunger crisis, and the world&rsquo;s largest displacement crisis.<!-- raw HTML omitted --><!-- raw HTML omitted -->On the surface, it&rsquo;s a story about two warring generals vying for power â€“ the latest in a long cycle of power struggles that have plagued Sudan for decades. But it&rsquo;s also a story about the U.S. war on terror, Russia&rsquo;s war in Ukraine, and China&rsquo;s global rise.<!-- raw HTML omitted --><!-- raw HTML omitted -->Today on the show, we turn back the clock more than a century to untangle the complex web that put Sudan on the path to war.<!-- raw HTML omitted --><!-- raw HTML omitted -->Learn more about &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39014993/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240717183322&amp;v=2.18.0.post9&#43;e462414">Practitioner Review: Continuity of mental health care from childhood to adulthood for youths with ADHDÂ -Â who, how and when?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39014993-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240717183322-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Many youths with attention-deficit/hyperactivity disorder (ADHD) experience significant long-term impairment and may develop concurrent mental and somatic health difficulties as adults. This is associated with burden and costs for the individual and society which could be prevented through continued support in youth. Yet, only few young people transition to adult mental health services for ongoing care in different countries worldwide. We provide an overview on current transition &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39015340/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240717183322&amp;v=2.18.0.post9&#43;e462414">Good mid- to long-term outcomes after meniscus bucket-handle tear repair: A comparative analysis with and without anterior cruciate ligament reconstruction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39015340-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240717183322-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Arthroscopic BHMT repair achieved good clinical outcomes and an acceptable failure rate of 9% at a mean follow-up of 7 years, supporting the clinical value of meniscal repair, including large BHMTs. Concurrent ACLR showed no impact on clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39015379/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240717183322&amp;v=2.18.0.post9&#43;e462414">Myeloid cell-derived interleukin-6 induces vascular dysfunction and vascular and systemic inflammation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39015379-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240717183322-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Mice with conditional overexpression of IL-6 in myeloid cells show systemic and vascular inflammation as well as endothelial dysfunction. A decrease in circulating IL-6 levels by replacing IL-6-producing myeloid cells in the BM improved vascular dysfunction in this model, underpinning the relevant role of IL-6 in vascular &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39015568/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240717183322&amp;v=2.18.0.post9&#43;e462414">Editorial: Impact of emerging treatment modalities on stromal cells in the tumour microenvironment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39015568-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240717183322-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39016006/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240717183322&amp;v=2.18.0.post9&#43;e462414">Exploring the Therapeutic Potential of C-Type Natriuretic Peptide for Preeclampsia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39016006-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240717183322-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Collectively, these data suggest that enhancing CNP signaling through NPR-B offers a potential therapeutic strategy to reduce systemic vascular constriction in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39017699/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240717183322&amp;v=2.18.0.post9&#43;e462414">Complex optical systems for individualized correction of presbyopia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39017699-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240717183322-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A multitude of available intraocular lens (IOL) models enable a personalized approach to presbyopia correction in order to meet each patient&rsquo;s needs. This review article discusses more complex approaches which can be useful in selected cases. The concept of reversible trifocality enables correction of presbyopia using a supplementary intraocular lens (IOL), which can be removed if necessary (e.g., intolerance to multifocal optics). The use of capsulotomy-fixated IOLs enables high precision &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39017949/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240717182923&amp;v=2.18.0.post9&#43;e462414">A versatile attention-based neural network for chemical perturbation analysis and its potential to aid surgical treatment: A experimental study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39017949-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240717182923-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Deep learning models have emerged as rapid, accurate, and effective approaches for clinical decisions. Through a combination of drug screening and deep learning models, drugs that may benefit patients before and after surgery can be discovered to reduce the risk of complications or speed recovery. However, most existing drug prediction methods have high data requirements and lack interpretability, which has a limited role in adjuvant surgical treatment. To address these limitations, we &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39017949/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240718181743&amp;v=2.18.0.post9&#43;e462414">A versatile attention-based neural network for chemical perturbation analysis and its potential to aid surgical treatment: A experimental study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39017949-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240718181743-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Deep learning models have emerged as rapid, accurate, and effective approaches for clinical decisions. Through a combination of drug screening and deep learning models, drugs that may benefit patients before and after surgery can be discovered to reduce the risk of complications or speed recovery. However, most existing drug prediction methods have high data requirements and lack interpretability, which has a limited role in adjuvant surgical treatment. To address these limitations, we &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018527/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018527-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The cumulative incidence of PASC during the first year after SARS-CoV-2 infection decreased over the course of the pandemic, but the risk of PASC remained substantial even among vaccinated persons who had SARS-CoV-2 infection in the omicron era. (Supported by the Department of Veterans &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018528/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Sotorasib for Vascular Malformations Associated with &lt;em&gt;KRAS&lt;/em&gt; G12C Mutation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018528-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    KRAS gain-of-function mutations are frequently observed in sporadic arteriovenous malformations. The mechanisms underlying the progression of such KRAS-driven malformations are still incompletely understood, and no treatments for the condition are approved. Here, we show the effectiveness of sotorasib, a specific KRAS G12C inhibitor, in reducing the volume of vascular malformations and improving survival in two mouse models carrying a mosaic Kras G12C mutation. We then administered sotorasib &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018529/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Viral Variants, Vaccinations, and Long Covid - New Insights</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018529-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018531">Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn&#39;s Disease.</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018531/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted -->Laurent Peyrin-Biroulet<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->Â <!-- raw HTML omitted -->&lt;a class=&ldquo;affiliation-link&rdquo; title=&ldquo;From the Department of Gastroenterology, INFINY Institute, INSERM NGERE, Centre Hospitalier RÃ©gional Universitaire de Nancy, VandÅ“uvre-lÃ¨s-Nancy, France (L.P.-B.); the Division of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018531/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn&#39;s Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018531-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this head-to-head clinical trial of risankizumab and ustekinumab involving patients with moderate-to-severe Crohn&rsquo;s disease who had had unacceptable side effects with anti-TNF therapy or an inadequate response to such therapy, risankizumab was noninferior to ustekinumab with respect to clinical remission at week 24 and superior with respect to endoscopic remission at week 48. (Funded by AbbVie; ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018532/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018532-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this placebo-controlled trial, postexposure prophylaxis with nirmatrelvir-ritonavir for 5 or 10 days did not significantly reduce the risk of symptomatic SARS-CoV-2 infection. (Funded by Pfizer; ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018533/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018533-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In children with severe hemophilia A, once-weekly prophylaxis with efanesoctocog alfa provided high sustained factor VIII activity in the normal to near-normal range (&gt;40 IU per deciliter) for 3 days and more than 10 IU per deciliter for almost 7 days after administration, leading to effective bleeding prevention. Efanesoctocog alfa was associated with mainly nonserious adverse events. (Funded by Sanofi and Sobi; XTEND-Kids ClinicalTrials.gov number, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018534/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Management of Insomnia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018534-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018535/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Conjunctival Papilloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018535-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018536/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Case 22-2024: A 30-Year-Old Woman with Postpartum Fever, Abdominal Pain, and Skin Ulcers</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018536-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018537/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Interleukin-23 p19 and Interleukin-12 p40, Head-to-Head, against Gut Inflammation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018537-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018538/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Bioengineered Factor VIII - More Innovation for Hemophilia A</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018538-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018539/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Case Series of Patients with Marburg Virus Disease, Equatorial Guinea, 2023</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018539-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018540/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">Sudan Virus Disease among Health Care Workers, Uganda, 2022</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018540-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018541/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018541-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39018542/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240718181716&amp;v=2.18.0.post9&#43;e462414">FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39018542-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240718181716-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39020050/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Detection of myeloma-associated osteolytic bone lesions with energy-integrating and photon-counting detector CT</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39020050-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: For myeloma-associated OL, PCD-CT demonstrated significantly higher sensitivity, especially with small size. Visualization of bone tissue and lesions was considered significantly better in PCD-CT than in EID-CT. This implies that PCD-CT scanners could potentially be used in the early detection of myeloma-associated bone &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39020181/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Split intein-mediated protein trans-splicing to express large dystrophins</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39020181-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Gene replacement using adeno-associated virus (AAV) vectors is a promising therapeutic approach for many diseases^(1,2). However, this therapeutic modality is challenged by the packaging capacity of AAVs (approximately 4.7 kilobases)Â³, limiting its application for disorders involving large coding sequences, such as Duchenne muscular dystrophy, with a 14 kilobase messenger RNA. Here we developed a new method for expressing large dystrophins by utilizing the protein trans-splicing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39020292/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240718182022&amp;v=2.18.0.post9&#43;e462414">Increased level of TXNIP and nuclear translocation of TXN is associated with end stage renal disease and development of multiplex renal tumours</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39020292-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240718182022-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The impaired TXNIP/TXN redox homeostasis might be associated with development of multiplex cancer especially of EVT in ESRD/ACRD &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OnVOChhS2">ä¸Šä¸€æœŸSTAT News podcast - Readout Loudçš„ä¸¤ä¸ªé‡‡è®¿æå¥½ã€‚ç¬¬ä¸€æ˜¯ç¾å›½ç°åœ¨biopharmï¼ˆç”Ÿç‰©åˆ¶è¯ä¸šï¼‰å°±ä¸šå¸‚åœºçš„æ•°æ®ã€‚è¿™æœŸèŠ‚ç›®è¯·äº†è¯¥æœºæ„è®°è€…Jonathan Wosenæ€»ç»“äº†ä»Š...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-onvochhs2/">
    
    
    
    
    
      
    
    ä¸Šä¸€æœŸSTAT News podcast - Readout Loudçš„ä¸¤ä¸ªé‡‡è®¿æå¥½ã€‚ç¬¬ä¸€æ˜¯ç¾å›½ç°åœ¨biopharmï¼ˆç”Ÿç‰©åˆ¶è¯ä¸šï¼‰å°±ä¸šå¸‚åœºçš„æ•°æ®ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™æœŸèŠ‚ç›®è¯·äº†è¯¥æœºæ„è®°è€…Jonathan Wosenæ€»ç»“äº†ä»Šå¹´ä¸ŠåŠå¹´ç¾å›½biopharmå°±ä¸šå¸‚åœºçš„æ•°æ®ï¼š2021å¹´å‰5ä¸ªæœˆï¼Œbiopharmæœ‰21366ä¸ªå¼€æ”¾çš„æ‹›è˜èŒä½ï¼Œ2024å¹´æœ‰12300ä¸ªã€‚2021å¹´ï¼Œbiopharmä¸€å…±æœ‰1516äººè¢«laidoffï¼ˆè£å‘˜ï¼‰ï¼Œ2023å¹´æœ‰21159äººï¼Œ2024å¹´ä¸ŠåŠå¹´æœ‰13811äººã€‚è¿™å®é™…ä¸Šæ˜¯Wosenåœ¨8ä¸ªæœˆæŠ¥é“çš„åç»­ï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_web_default</a>. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OnXEpivx0">è°¢è°¢è®°å½•å…¨è¿‡ç¨‹ã€‚å¯¹ä½ çš„ç»å†æ·±è¡¨åŒæƒ…ã€‚è¯´äº†8å¹´äº†ï¼Œå…¶å®å¤§éƒ¨åˆ†ç¾å›½åäººå·ç²‰ç”Ÿæ´»åœ¨ä»–ä»¬çš„æ¹¾åŒºã€è¥¿é›…å›¾ã€çº½çº¦ã€LAå’Œæ³¢å£«é¡¿ä¸­æ–‡bubbleé‡Œï¼ˆä¸­æ–‡ç¤¾äº¤åœˆå’Œä¸­æ–‡ä¿¡æ¯æ¥æº...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-onxepivx0/">
    
    
    
    
    
      
    
    è°¢è°¢è®°å½•å…¨è¿‡ç¨‹ã€‚å¯¹ä½ çš„ç»å†æ·±è¡¨åŒæƒ…ã€‚è¯´äº†8å¹´äº†ï¼Œå…¶å®å¤§éƒ¨åˆ†ç¾å›½åäººå·ç²‰ç”Ÿæ´»åœ¨ä»–ä»¬çš„æ¹¾åŒºã€è¥¿é›…å›¾ã€çº½çº¦ã€LAå’Œæ³¢å£«é¡¿ä¸­æ–‡bubbleé‡Œï¼ˆä¸­æ–‡ç¤¾äº¤åœˆå’Œä¸­æ–‡ä¿¡æ¯æ¥æºï¼‰ï¼Œé”™è§‰è‡ªå·±è¿˜ç”Ÿæ´»åœ¨å›½å†…åäººå•æ°‘æ—ç¤¾ä¼šä¸­ã€‚å¾ˆå¤šäººä¹Ÿç¼ºä¹subtle communicationèƒ½åŠ›ï¼Œä¸çŸ¥é“å¾ˆå¤šä¾®è¾±æ€§è¯æ±‡çš„å«ä¹‰ã€‚è€Œè‡ªå·±ä»…å–„äºåœ¨ä¸­æ–‡ç½‘ç»œ&hellip;<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@isekisié‡Œçš„æ—‹è½¬å°å­—<!-- raw HTML omitted -->:â€‚è®°å½•ä¸€ä¸‹7/13å‘¨å…­æˆ‘åœ¨çº½çº¦ä¹…çŸ³è®©æ¼”å¥ä¼šä¸Šè¢«ç™½ç”·ç§æ—æ­§è§†ï¼Œå¹¶è¢«æš´åŠ›å¨èƒå’Œè¾±éª‚chinkçš„ç»è¿‡ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æˆ‘å’Œæˆ‘å¯¹è±¡çš„ä½å­åœ¨Sec 108çš„å‰æ’ï¼Œè™½ç„¶ç¦»èˆå°å¾ˆè¿‘ä½†æ˜¯è§†çº¿ç¨ç¨æœ‰é˜»ã€‚å¤§æ¦‚åœ¨å¼€åœºå‰15åˆ†é’Ÿï¼Œæœ‰ä¸€å®¶äº”å£ç™½äººï¼ˆå¦ˆå¦ˆï¼Œçˆ¸çˆ¸ï¼Œä¸‰ä¸ªå„¿å­ï¼‰ååœ¨äº†æˆ‘ä»¬åé¢ä¸€æ’ã€‚ä»–ä»¬åˆšå…¥åº§çš„æ—¶å€™æˆ‘å°± &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Oo4gqkufE">ä»Šå¤©ä»æ—©ä¸Š7ç‚¹å¼€ä¼šä¸€ç›´å¼€åˆ°ç°åœ¨ã€‚åœ¨æ€»éƒ¨å¥½å¤„æ˜¯å…¨ä¸–ç•Œå„åœ°çš„åŒäº‹éƒ½ä¼šå®šæœŸåˆ°è¿™é‡Œæ¥å¼€ä¼šï¼Œæ‰€ä»¥å¯ä»¥è·Ÿä»–ä»¬ä¸€èµ·èšä¼šå’Œåƒé¥­å¹¶å¬å†…å¹•æ¶ˆæ¯ã€‚ä»Šå¤©åœ¨æ¬§æ´²å·¥ä½œå’Œç”Ÿæ´»çš„ç¾å›½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oo4gqkufe/">
    
    
    
    
    
      
    
    ä»Šå¤©ä»æ—©ä¸Š7ç‚¹å¼€ä¼šä¸€ç›´å¼€åˆ°ç°åœ¨ã€‚åœ¨æ€»éƒ¨å¥½å¤„æ˜¯å…¨ä¸–ç•Œå„åœ°çš„åŒäº‹éƒ½ä¼šå®šæœŸåˆ°è¿™é‡Œæ¥å¼€ä¼šï¼Œæ‰€ä»¥å¯ä»¥è·Ÿä»–ä»¬ä¸€èµ·èšä¼šå’Œåƒé¥­å¹¶å¬å†…å¹•æ¶ˆæ¯ã€‚ä»Šå¤©åœ¨æ¬§æ´²å·¥ä½œå’Œç”Ÿæ´»çš„ç¾å›½åŒäº‹è®²åœ¨æ¬§æ´²çš„å„ç§è¶£äº‹ï¼Œå¤§å®¶éƒ½åŒæ„å“¥æœ¬å“ˆæ ¹æ˜¯æœ€ç¾å¥½çš„æ¬§æ´²åŸå¸‚ã€‚  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/Oo4Lt0MlQ">é‡è¦é•¿æ–°å† å‘ç—…ç‡ç ”ç©¶ã€‚NEJMåˆšåˆšä¸Šçº¿äº†åœ¨é•¿æ–°å† ï¼ˆPASCï¼‰ä¸´åºŠç ”ç©¶ä¸­åšå‡ºäº†å“è¶Šè´¡çŒ®çš„St. Louis VAçš„ä¸€é¡¹å…³é”®ä¸´åºŠé˜Ÿåˆ—ç ”ç©¶ã€‚è€Œå…¶ä¸€é¡¹æœ€æ–°ç ”ç©¶åˆšåˆšå‘è¡¨åœ¨Nature Med...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-oo4lt0mlq/">
    
    
    
    
    
      
    
    é‡è¦é•¿æ–°å† å‘ç—…ç‡ç ”ç©¶ã€‚NEJMåˆšåˆšä¸Šçº¿äº†åœ¨é•¿æ–°å† ï¼ˆPASCï¼‰ä¸´åºŠç ”ç©¶ä¸­åšå‡ºäº†å“è¶Šè´¡çŒ®çš„St. Louis VAçš„ä¸€é¡¹å…³é”®ä¸´åºŠé˜Ÿåˆ—ç ”ç©¶ã€‚è€Œå…¶ä¸€é¡¹æœ€æ–°ç ”ç©¶åˆšåˆšå‘è¡¨åœ¨Nature Medä¸Šï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ã€‚è¿™é¡¹æœ€æ–°ç ”ç©¶ä¸»è¦æ¢è®¨äº†åœ¨Deltaçªå˜æ ªä¹‹å‰ã€Deltaå’ŒOmicronä¸‰ä¸ªæ—¶æœŸçš„PASCå‘ç”Ÿæƒ…å†µã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™é¡¹ç ”ç©¶åˆ†æäº†2020å¹´3æœˆè‡³2022å¹´1æœˆ44158 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oo1D1mG8V">ğŸ”»æ™®äº¬ï¼šåœ¨ä¿„ç½—æ–¯ï¼ŒåŠ å¯†è´§å¸æŒ–çŸ¿å èƒ½æºæ¶ˆè€—æ€»é‡çš„1.5%ï¼Œè¿™ä¸€æ•°å­—è¿˜åœ¨æŒç»­å¢é•¿ï¼Œç”±äºåŠ å¯†è´§å¸æŒ–çŸ¿çš„å¢é•¿ï¼Œå¤šä¸ªåœ°åŒºé¢ä¸´ç”µåŠ›çŸ­ç¼ºçš„é£é™©ã€‚ä¸èƒ½è¿™æ ·æŒç»­ä¸‹å»ã€‚ğŸ”»...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oo1d1mg8v/">
    
    
    
    
    
      
    
    ğŸ”»æ™®äº¬ï¼šåœ¨ä¿„ç½—æ–¯ï¼ŒåŠ å¯†è´§å¸æŒ–çŸ¿å èƒ½æºæ¶ˆè€—æ€»é‡çš„1.5%ï¼Œè¿™ä¸€æ•°å­—è¿˜åœ¨æŒç»­å¢é•¿ï¼Œç”±äºåŠ å¯†è´§å¸æŒ–çŸ¿çš„å¢é•¿ï¼Œå¤šä¸ªåœ°åŒºé¢ä¸´ç”µåŠ›çŸ­ç¼ºçš„é£é™©ã€‚ä¸èƒ½è¿™æ ·æŒç»­ä¸‹å»ã€‚<!-- raw HTML omitted -->ğŸ”»via vk/smotri_media <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com">https://f.video.weibocdn.com</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oo1DE5mYt">ğŸ”»æœ‰äººç»™æ‹œç™»å‡ºä¸»æ„ï¼Œè®©ä»–å’Œé©¬å…‹é¾™ä¸€èµ·å»å¡çº³æ²³æ¸¸æ³³ã€‚ğŸ”»â€œæ¯”ç‰¹æœ—æ™®æ›´å¼•äººæ³¨ç›®çš„ä¸œè¥¿â€ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oo1de5myt/">
    
    
    
    
    
      
    
    ğŸ”»æœ‰äººç»™æ‹œç™»å‡ºä¸»æ„ï¼Œè®©ä»–å’Œé©¬å…‹é¾™ä¸€èµ·å»å¡çº³æ²³æ¸¸æ³³ã€‚<!-- raw HTML omitted -->ğŸ”»â€œæ¯”ç‰¹æœ—æ™®æ›´å¼•äººæ³¨ç›®çš„ä¸œè¥¿â€ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax1.sinaimg.cn/orj480/639b1bfbly1hrrfkyuu1ej20k00zkmyl.jpg%22">https://tvax1.sinaimg.cn/orj480/639b1bfbly1hrrfkyuu1ej20k00zkmyl.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oo1Gks1T4">ğŸ”»å°é‡‘æ¯›è·‘å»è§å·æ™®äº†ï¼Œä»–è¯´ï¼šâ€œå¾ˆé«˜å…´èƒ½è§åˆ°ç‰¹æœ—æ™®æ€»ç»Ÿï¼Œä»–åœ¨ç»å†äº†å¯è€»çš„æœªé‚è°‹æ€äº‹ä»¶åçŠ¶æ€æ­£ä½³ã€‚æˆ‘ä»¬è®¨è®ºäº†ä¹Œå…‹å…°é—®é¢˜ï¼Œæˆ‘æ¯«ä¸æ€€ç–‘ä»–å°†åšå®šæœæ–­åœ°æ”¯æŒä¹Œå…‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oo1gks1t4/">
    
    
    
    
    
      
    
    ğŸ”»å°é‡‘æ¯›è·‘å»è§å·æ™®äº†ï¼Œä»–è¯´ï¼šâ€œå¾ˆé«˜å…´èƒ½è§åˆ°ç‰¹æœ—æ™®æ€»ç»Ÿï¼Œä»–åœ¨ç»å†äº†å¯è€»çš„æœªé‚è°‹æ€äº‹ä»¶åçŠ¶æ€æ­£ä½³ã€‚æˆ‘ä»¬è®¨è®ºäº†ä¹Œå…‹å…°é—®é¢˜ï¼Œæˆ‘æ¯«ä¸æ€€ç–‘ä»–å°†åšå®šæœæ–­åœ°æ”¯æŒä¹Œå…‹å…°ï¼Œæå«æ°‘ä¸»ã€‚â€<!-- raw HTML omitted -->ğŸ”»ä¹ã€‚<!-- raw HTML omitted -->ğŸ”»via skynews <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oo1HXuqcu">ğŸ”»â€œç¾å›½å’Œï¼ˆ ï¼‰â€ åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oo1hxuqcu/">
    
    
    
    
    
      
    
    ğŸ”»â€œç¾å›½å’Œï¼ˆ ï¼‰â€ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/A5QEnKGelx08gvdjYwi4010412003ATD0E010.mp4?label">https://f.video.weibocdn.com/o0/A5QEnKGelx08gvdjYwi4010412003ATD0E010.mp4?label</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oo1Ldn3cJ">ğŸ”»æœ‰äººåœ¨å½­è¨ç§‘æ‹‰æµ·æ»©å°†æ— äººæœºç›´æ¥é£åˆ°è“å¤©ä½¿çš„é£è¡Œè·¯çº¿ä¸Šã€‚ğŸ”»ç„¶åå°†è§†é¢‘å‘å¸ƒåœ¨è“å¤©ä½¿ Fb é¡µé¢ä¸Šã€‚ğŸ”»é£é¾™éª‘è„¸å•Šï¼Œå¤ªé£éªšäº†ã€‚ğŸ”»è¿™æ ·æŠ½è±¡çš„æ“ä½œï¼Œä»¥è‡³äºä¿„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oo1ldn3cj/">
    
    
    
    
    
      
    
    ğŸ”»æœ‰äººåœ¨å½­è¨ç§‘æ‹‰æµ·æ»©å°†æ— äººæœºç›´æ¥é£åˆ°è“å¤©ä½¿çš„é£è¡Œè·¯çº¿ä¸Šã€‚<!-- raw HTML omitted -->ğŸ”»ç„¶åå°†è§†é¢‘å‘å¸ƒåœ¨è“å¤©ä½¿ Fb é¡µé¢ä¸Šã€‚<!-- raw HTML omitted -->ğŸ”»é£é¾™éª‘è„¸å•Šï¼Œå¤ªé£éªšäº†ã€‚<!-- raw HTML omitted -->ğŸ”»è¿™æ ·æŠ½è±¡çš„æ“ä½œï¼Œä»¥è‡³äºä¿„å›½äººéƒ½å…´é«˜é‡‡çƒˆçš„è½¬å‘åˆ° VK å˜²ç¬‘äº†ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax2.sinaimg.cn/orj480/639b1bfbly1hrrg4hl24cj20u0">https://tvax2.sinaimg.cn/orj480/639b1bfbly1hrrg4hl24cj20u0</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oo1Qtplfw">ğŸ”»ä¸€æ¶ SU-34 åœ¨èƒ½çœ‹åˆ°åœ°å¹³çº¿å¼§åº¦çš„é«˜åº¦ï¼ŒæŠ•ä¸‹äº†ä¸€å‘ FAB-3000ï¼ˆï¼Ÿï¼‰ğŸ”»via vk åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oo1qtplfw/">
    
    
    
    
    
      
    
    ğŸ”»ä¸€æ¶ SU-34 åœ¨èƒ½çœ‹åˆ°åœ°å¹³çº¿å¼§åº¦çš„é«˜åº¦ï¼ŒæŠ•ä¸‹äº†ä¸€å‘ FAB-3000ï¼ˆï¼Ÿï¼‰<!-- raw HTML omitted -->ğŸ”»via vk <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o">https://f.video.weibocdn.com/o</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oo1Tcpvzs">ğŸ”»ï¼Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oo1tcpvzs/">
    
    
    
    
    
      
    
    ğŸ”»ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oo1XB3oX8">ğŸ”»ä¸ä»…ä¸œæ–¹æ–‡åŒ–éš¾ä»¥ç†è§£è¿™ç§äº‹æƒ…ï¼Œè¥¿æ–¹æ–‡åŒ–ä¸­é•¿å¤§çš„å¤§éƒ¨åˆ†äººå…¶å®ä¹Ÿä¸èƒ½ç†è§£ã€‚ğŸ”¹ç¾å›½ç½‘å‹è¯´ï¼šâ€œI canâ€™t imagine kicking my kids out at any age. They will...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oo1xb3ox8/">
    
    
    
    
    
      
    
    ğŸ”»ä¸ä»…ä¸œæ–¹æ–‡åŒ–éš¾ä»¥ç†è§£è¿™ç§äº‹æƒ…ï¼Œè¥¿æ–¹æ–‡åŒ–ä¸­é•¿å¤§çš„å¤§éƒ¨åˆ†äººå…¶å®ä¹Ÿä¸èƒ½ç†è§£ã€‚<!-- raw HTML omitted -->ğŸ”¹ç¾å›½ç½‘å‹è¯´ï¼šâ€œI canâ€™t imagine kicking my kids out at any age. They will always be welcomed no strings attachedâ€”â€”æˆ‘æ— æ³•æƒ³è±¡åœ¨ä»»ä½•å¹´é¾„æ®µæŠŠæˆ‘çš„å­©å­èµ¶å‡ºå»ã€‚å¥¹ä»¬å°†æ°¸è¿œå—åˆ°æ— æ¡ä»¶çš„æ¬¢è¿ã€‚â€<!-- raw HTML omitted -->ğŸ”¹ä»¥åŠï¼šâ€œThat is so messed up. My daughter is over 30 &amp; could live with us if she needed toâ€”â€”çœŸæ˜¯ä¸€å›¢ç³Ÿã€‚æˆ‘å¥³å„¿å·²ç» 30 å¤šå²äº†ï¼Œå¦‚æœéœ€è¦çš„è¯ï¼Œå¥¹éšæ—¶å¯ä»¥å’Œæˆ‘ä»¬ä½åœ¨ä¸€èµ·ã€‚â€<!-- raw HTML omitted -->ğŸ”¹â€œI&rsquo;ve seen so many interviews of unhoused people whose parents gave them that same level of &ldquo;pushing out of the nest, rough loveâ€”â€”æˆ‘çœ‹è¿‡å¾ˆå¤šå…³äºæ— å®¶å¯å½’è€…çš„é‡‡è®¿ï¼Œä»–ä»¬çš„çˆ¶æ¯ä¹Ÿç»™äº†ä»–ä»¬åŒæ ·ç¨‹åº¦çš„â€˜æ¨ç¦»å·¢ç©´ã€ç²—æš´çš„çˆ±â€™ã€‚â€<!-- raw HTML omitted -->ğŸ”¹â€œMy kid will always have a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oo21v0zjt">ğŸ”»ç”±äºç”µåŠ›å’Œä¾›æš–é—®é¢˜ï¼Œä¹Œå…‹å…°çš„ä¸€äº›å•†åº—å·²åœæ­¢é”€å”®æ˜“è…çƒ‚çš„é£Ÿå“ã€‚ğŸ”»è§†é¢‘ä¸­ç¬¬è‚ä¼¯ç½—å½¼å¾—ç½—å¤«æ–¯å…‹ä¸€å®¶è¶…å¸‚çš„é¦™è‚ å’Œä¹³åˆ¶å“éƒ¨é—¨å·²å…³é—­ã€‚ğŸ”»via vk åŒ…å®¹ä¸‡ç‰©æ’...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oo21v0zjt/">
    
    
    
    
    
      
    
    ğŸ”»ç”±äºç”µåŠ›å’Œä¾›æš–é—®é¢˜ï¼Œä¹Œå…‹å…°çš„ä¸€äº›å•†åº—å·²åœæ­¢é”€å”®æ˜“è…çƒ‚çš„é£Ÿå“ã€‚<!-- raw HTML omitted -->ğŸ”»è§†é¢‘ä¸­ç¬¬è‚ä¼¯ç½—å½¼å¾—ç½—å¤«æ–¯å…‹ä¸€å®¶è¶…å¸‚çš„é¦™è‚ å’Œä¹³åˆ¶å“éƒ¨é—¨å·²å…³é—­ã€‚<!-- raw HTML omitted -->ğŸ”»via vk <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax2.sinaimg.cn/orj480/639b1bfbly1hrrham9ofaj20jk0zk74z.jpg%22">https://tvax2.sinaimg.cn/orj480/639b1bfbly1hrrham9ofaj20jk0zk74z.jpg&quot;</a> style=&ldquo;width: &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Oo2lf7htY">ğŸ”»ä¹å±±è¿™ä¼šå„¿é›¨å¾ˆå¤§å—ï¼Ÿ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oo2lf7hty/">
    
    
    
    
    
      
    
    ğŸ”»ä¹å±±è¿™ä¼šå„¿é›¨å¾ˆå¤§å—ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/Oo01liBqh">å“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆæ•‘å‘½å•Šä½ è¿™//@é¸¢å°¾è‰ii:æ”¶è—äº†ï¼Œä¸ŠåŠçš„æ—¶å€™æ‹¿å‡ºæ¥çœ‹çœ‹ï¼Œæ‰“ç»“éƒ½æœ‰åŠ² - è½¬å‘ @å†²æµªç”·å­©é’»é’»å­:&amp;ensp;åŸæ¥æˆç»©ä¸å¥½æ˜¯ä¸ç”¨æŒ¨éª‚çš„#å¤æ—¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-oo01libqh/">
    
    
    
    
    
      
    
    å“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆæ•‘å‘½å•Šä½ è¿™//<!-- raw HTML omitted -->@é¸¢å°¾è‰ii<!-- raw HTML omitted -->:æ”¶è—äº†ï¼Œä¸ŠåŠçš„æ—¶å€™æ‹¿å‡ºæ¥çœ‹çœ‹ï¼Œæ‰“ç»“éƒ½æœ‰åŠ²<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å†²æµªç”·å­©é’»é’»å­<!-- raw HTML omitted -->:â€‚åŸæ¥æˆç»©ä¸å¥½æ˜¯ä¸ç”¨æŒ¨éª‚çš„<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å¤æ—¥æ•´æ´»æ—¥è®°#<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9A%91">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E6%9A%91</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OnXMrmGPr">å°å–µæƒ³è€å–µçˆ·çˆ·çš„æ‰‹æœºï¼Œå–µçˆ·çˆ·å°±ç»™ä»–ã€‚å–µå¥¶å¥¶å¤§æ€’ï¼Œå°†å–µçˆ·çˆ·é©±é€å›å®¶ï¼Œæ–­äº†å°å–µçš„å¿µæƒ³ã€‚å–µçˆ·çˆ·è¯´æˆ‘ä¸åœ¨ï¼Œä½ ä»¬åƒé¥­å’‹ä¸ªåŠï¼Ÿå–µå¥¶å¥¶è¯´ä½ æ”¾å¿ƒï¼Œç°åœ¨é¥¿ä¸æ­»äººï¼å–µçˆ·çˆ·...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-onxmrmgpr/">
    
    
    
    
    
      
    
    å°å–µæƒ³è€å–µçˆ·çˆ·çš„æ‰‹æœºï¼Œå–µçˆ·çˆ·å°±ç»™ä»–ã€‚å–µå¥¶å¥¶å¤§æ€’ï¼Œå°†å–µçˆ·çˆ·é©±é€å›å®¶ï¼Œæ–­äº†å°å–µçš„å¿µæƒ³ã€‚å–µçˆ·çˆ·è¯´æˆ‘ä¸åœ¨ï¼Œä½ ä»¬åƒé¥­å’‹ä¸ªåŠï¼Ÿå–µå¥¶å¥¶è¯´ä½ æ”¾å¿ƒï¼Œç°åœ¨é¥¿ä¸æ­»äººï¼å–µçˆ·çˆ·è‡ªè®¨æ²¡è¶£ï¼Œåšä¸€å¤§ç›˜ç•ªèŒ„é¸¡è›‹æ„é¢å®‰æ…°è‡ªå·±ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OnXWHonrx">å…³æ³¨//@æˆéƒ½å†¯å·:è½¬å‘å¾®åš - è½¬å‘ @[åŸå¾®åšä¸å¯è®¿é—®]:&amp;ensp;è¯¥å¾®åšå› è¢«å¤šäººæŠ•è¯‰ï¼Œæ ¹æ®ã€Šå¾®åšç¤¾åŒºå…¬çº¦ã€‹ï¼Œå·²è¢«åˆ é™¤ã€‚æŸ¥çœ‹å¸®åŠ©ï¼š ç½‘é¡µé“¾æ¥</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-onxwhonrx/">
    
    
    
    
    
      
    
    å…³æ³¨//<!-- raw HTML omitted -->@æˆéƒ½å†¯å·<!-- raw HTML omitted -->:è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@[åŸå¾®åšä¸å¯è®¿é—®]<!-- raw HTML omitted -->:â€‚è¯¥å¾®åšå› è¢«å¤šäººæŠ•è¯‰ï¼Œæ ¹æ®ã€Šå¾®åšç¤¾åŒºå…¬çº¦ã€‹ï¼Œå·²è¢«åˆ é™¤ã€‚æŸ¥çœ‹å¸®åŠ©ï¼š<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OnYN8whxB">å‡ºç‰ˆç¤¾æ‹Ÿäºä¸‹å‘¨æœ«åœ¨æˆéƒ½æµ®äºé‡ä¹¦åº—å’Œä¸‰è”éŸ¬å¥‹ä¹¦åº—ä¸¾è¡Œã€Šç§è±†å¾—ç“œé›†ã€‹ç­¾å”®æ´»åŠ¨ï¼Œè¯·æˆ‘æä¾›ä¸€äº›å…»é¸¡å…»çŒ«ç§ç“œç§èœçš„ç…§ç‰‡ã€‚ä¹¦åº—å¯èƒ½æŠŠæ­¤ä¹¦å½“æˆç°ä»£å‡é™¶æ¸Šæ˜çš„éƒ½å¸‚ç”°å›­...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-onyn8whxb/">
    
    
    
    
    
      
    
    å‡ºç‰ˆç¤¾æ‹Ÿäºä¸‹å‘¨æœ«åœ¨æˆéƒ½æµ®äºé‡ä¹¦åº—å’Œä¸‰è”éŸ¬å¥‹ä¹¦åº—ä¸¾è¡Œã€Šç§è±†å¾—ç“œé›†ã€‹ç­¾å”®æ´»åŠ¨ï¼Œè¯·æˆ‘æä¾›ä¸€äº›å…»é¸¡å…»çŒ«ç§ç“œç§èœçš„ç…§ç‰‡ã€‚ä¹¦åº—å¯èƒ½æŠŠæ­¤ä¹¦å½“æˆç°ä»£å‡é™¶æ¸Šæ˜çš„éƒ½å¸‚ç”°å›­ç”Ÿæ´»å®å½•äº†ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/Oo1eEmMa0">å–µçˆ·çˆ·æ›¾ç»æ”¶å…»æµæµªçŒ«ï¼Œå››ä¸–åŒå ‚ï¼Œç››å†µç©ºå‰ã€‚ä¸å°‘ç½‘å‹ä»¥ä¸ºå–µçˆ·çˆ·æœ‰çˆ±å¿ƒï¼Œä»åŠä¸‡ç‰©ï¼Œå„’å®¶æ‰€è°“â€œäº²äº²è€Œä»æ°‘ï¼Œä»æ°‘è€Œçˆ±ç‰©â€ï¼Œâ€œä»è€…ä»¥å¤©åœ°ä¸‡ç‰©ä¸ºä¸€ä½“â€ï¼Œâ€œæ°‘å¾åŒèƒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oo1eemma0/">
    
    
    
    
    
      
    
    å–µçˆ·çˆ·æ›¾ç»æ”¶å…»æµæµªçŒ«ï¼Œå››ä¸–åŒå ‚ï¼Œç››å†µç©ºå‰ã€‚ä¸å°‘ç½‘å‹ä»¥ä¸ºå–µçˆ·çˆ·æœ‰çˆ±å¿ƒï¼Œä»åŠä¸‡ç‰©ï¼Œå„’å®¶æ‰€è°“â€œäº²äº²è€Œä»æ°‘ï¼Œä»æ°‘è€Œçˆ±ç‰©â€ï¼Œâ€œä»è€…ä»¥å¤©åœ°ä¸‡ç‰©ä¸ºä¸€ä½“â€ï¼Œâ€œæ°‘å¾åŒèƒï¼Œç‰©å¾ä¸ä¹Ÿâ€ã€‚å…¶å®ä¸ç„¶ï¼Œæˆ‘æ²¡é‚£ä¹ˆé«˜çš„å¢ƒç•Œã€‚æˆ‘æ”¶å…»æµæµªçŒ«çš„ç›®çš„ï¼Œå¾ˆåŠŸåˆ©ï¼Œå°±æ˜¯æŠ“è€é¼ ã€‚ä¸ç®¡é»‘çŒ«ç™½çŒ«ï¼Œèƒ½æŠ“è€é¼ å°±æ˜¯å¥½çŒ«ã€‚<!-- raw HTML omitted --> ä»Šå¤©ä¸ºæ–°ä¹¦ã€Šç§è±†å¾—ç“œé›†ã€‹ç­¾å”®æ´»åŠ¨è´´çš„å‡ å¼ å–µæ˜Ÿäººç…§ç‰‡ï¼Œå¿…é¡»è¯´æ˜ä¸€ä¸‹ï¼šå›¾1ï¼ŒæŠ“é¼ å…ƒå‹‹ï¼Œæˆ‘å› æ­¤å‘å‡ºæ‹›è˜å¯äº‹ï¼šè¯šè˜æŠ“è€é¼ çš„é’Ÿç‚¹å·¥ï¼Œç”·å¥³ä¸é™ï¼Œå¹´é¾„ä¸é™ï¼ŒåŒ…åƒä¸åŒ…ä½ï¼›å›¾2ï¼Œç¬¬ä¸€ä½åº”è˜è€…ï¼Œå–µå–µå–µï¼Œæˆ‘å°±æ˜¯æ¥åº”è˜çš„ï¼›å›¾3ï¼Œç¬¬äºŒä½åº”è˜è€…ï¼Œæˆ‘ä¹Ÿæ˜¯æ¥åº”è˜çš„ï¼ä½†è°ƒæŸ¥å‘ç°ï¼Œæ˜¯ç¬¬ä¸€ä½åº”è˜è€…çš„è€å…¬ï¼Œå¥½åƒæ‡’åšï¼Œä¸ä¿®è¾¹å¹…ï¼Œè¢«æ·˜æ±°ï¼›å›¾4ï¼Œå¤©å¤©ç”Ÿè›‹ã€åˆ›é€ é¸¡çš„å±GDPçš„çº¯æƒ…æ¯é¸¡æ€’æ€¼åˆšå…¥èŒå°±åƒç‰¹ä¾›çš„å–µæ˜Ÿäººï¼Œä½ å¨ƒåˆæ¥ä¹åˆ°ï¼Œå‡­å•¥å­åƒç‰¹ä¾›ï¼Ÿå–µæ˜Ÿäººè¯´æˆ‘ä»¬æœ‰ç‰¹æ®Šä»»åŠ¡ï¼å›¾5ï¼Œå–µæ˜Ÿäººå…¥èŒä¸åˆ°åŠå¹´ï¼Œå°±æ€€å­•ç”Ÿå­ï¼Œä¸€èƒå››å­ï¼Œä¸ªä¸ªæ°”å®‡è½©æ˜‚ï¼Œä¸å¯ä¸€ä¸–ï¼šæˆ‘å¦ˆæ˜¯åƒç‰¹ä¾›çš„ï¼å›¾6ï¼ŒçŒ«å¦ˆå¦ˆè¶æˆ‘æ”¹é©å¼€æ”¾å›½é—¨å¤§å¼€ä¹‹é™…ï¼Œæ‹–å„¿å¸¦å¥³ç™»å ‚å…¥å®¤ï¼Œæ½œä¼ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/OnXiWoI85">ç­”æ¡ˆï¼šé•¿æ±Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-onxiwoi85/">
    
    
    
    
    
      
    
    ç­”æ¡ˆï¼šé•¿æ±Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/Oo0zTCAiZ">æ ¹æ®ç§‹åˆ€é±¼æ–°é›„æ–‡ï¼Œæ˜¯å¦å¯è®¤å®šä»–ä¸ºâ€œèµ„æ·±æŸ¯ç²‰â€ğŸ‘¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-oo0ztcaiz/">
    
    
    
    
    
      
    
    æ ¹æ®ç§‹åˆ€é±¼æ–°é›„æ–‡ï¼Œæ˜¯å¦å¯è®¤å®šä»–ä¸ºâ€œèµ„æ·±æŸ¯ç²‰â€ğŸ‘¿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OnYS0vQNu">æœ¬äººè¿™æ¬¡å‡ºæ¥åšå¾—æœ€æ­£ç¡®çš„é€‰æ‹©ï¼šå¸¦äº†ä¸€ä»¶è¡¬è¡«ğŸ«°ğŸ»</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-onys0vqnu/">
    
    
    
    
    
      
    
    æœ¬äººè¿™æ¬¡å‡ºæ¥åšå¾—æœ€æ­£ç¡®çš„é€‰æ‹©ï¼š<!-- raw HTML omitted -->å¸¦äº†ä¸€ä»¶è¡¬è¡«ğŸ«°ğŸ»  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OnYTZaSxJ">æ€ä¹ˆä¸ç®—ä¸€èµ·æ—…è¡Œ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-onytzasxj/">
    
    
    
    
    
      
    
    æ€ä¹ˆä¸ç®—ä¸€èµ·æ—…è¡Œ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OnYXK2Ug3">ğŸ’å¿˜ã‚Œã¦ãã ã•ã„</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-onyxk2ug3/">
    
    
    
    
    
      
    
    ğŸ’<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å¿˜ã‚Œã¦ãã ã•ã„<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oo0FGdzod">[æœ‰ç¥¨äº†][æœ‰ç¥¨äº†] é½é½å“ˆå°”Â·é½é½å“ˆå°”å—ç«™ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oo0fgdzod/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oo1o8hUnd">ç»‡å„¿çš„è‚šè‚šå”‰æˆ‘ä¸å…è®¸æœ‰äººè¯´ä¸å¥½çœ‹ğŸ¥µğŸ¥¹ğŸ«°ğŸ» - è½¬å‘ @åƒè‘‰é±¿é±¼:&amp;ensp;24å¹´8æœˆ21æ—¥å‘å”®çš„ä¹ƒæœ¨å‚46 36å•æ ‡é¢˜ä¸ºã€Œãƒãƒ¼ãƒˆãƒ‡ã‚¤ã€è‰ºæœ¯ç…§å…¬å¼€ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oo1o8hund/">
    
    
    
    
    
      
    
    ç»‡å„¿çš„è‚šè‚šå”‰æˆ‘ä¸å…è®¸æœ‰äººè¯´ä¸å¥½çœ‹ğŸ¥µğŸ¥¹ğŸ«°ğŸ»<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åƒè‘‰é±¿é±¼<!-- raw HTML omitted -->:â€‚24å¹´8æœˆ21æ—¥å‘å”®çš„<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ƒæœ¨å‚46<!-- raw HTML omitted --><!-- raw HTML omitted --> 36å•æ ‡é¢˜ä¸ºã€Œãƒãƒ¼ãƒˆãƒ‡ã‚¤ã€<!-- raw HTML omitted -->è‰ºæœ¯ç…§å…¬å¼€ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/l">https://tvax1.sinaimg.cn/l</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oo1p7820I">å˜¬å˜¬å˜¬ğŸ’• [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oo1p7820i/">
    
    
    
    
    
      
    
    å˜¬å˜¬å˜¬ğŸ’• <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oo2hijnQ6">å¤ªå¯çˆ±äº†æƒ³ä¸ºå¥¹åšä¸€åˆ‡ - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ via.ä¹ƒæœ¨å‚46 &amp;NOGI46ann X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oo2hijnq6/">
    
    
    
    
    
      
    
    å¤ªå¯çˆ±äº†æƒ³ä¸ºå¥¹åšä¸€åˆ‡<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.ä¹ƒæœ¨å‚46 &amp;NOGI46ann X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hrrgjeh">https://tvax2.sinaimg.cn/large/006z6nxLgy1hrrgjeh</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oo2hlfBui">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ç¨å25:00ï½ï¼ˆJSTï¼‰æ—¥æœ¬æ”¾é€ã€ä¹ƒæœ¨å‚46çš„ANNã€è¯·ä¸€å®šè¦å¬â€¦â˜ºï¸ãƒŠã‚¤ãƒŠã‚¤æ¡‘è¾›è‹¦äº†â€¦ï¼âœ¨ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oo2hlfbui/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%252">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/Oo2hq8bwL">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ via.NOGI46ann Xã€Œæ£’çƒå°‘å¥³@ comic é¹«å°¾å¸Œæœ›ä¿æŒä¹å¤©ã€çš„å•è¡Œæœ¬æ¼«ç”»ç¬¬ä¸€å·å†³å®šå°†äº9æœˆ25æ—¥å‘å”® [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-oo2hq8bwl/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.NOGI46ann X<!-- raw HTML omitted -->ã€Œæ£’çƒå°‘å¥³@ comic é¹«å°¾å¸Œæœ›ä¿æŒä¹å¤©ã€çš„å•è¡Œæœ¬æ¼«ç”»ç¬¬ä¸€å·å†³å®šå°†äº9æœˆ25æ—¥å‘å”® &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OnXDcFCw1">æ£‹æ‰‹æˆ˜é¹° ä¸»åŒ…æ¥å—äº†ã€Šsixth toneï¼ˆç¬¬å…­å£°ï¼‰ã€‹çš„é‡‡è®¿ï¼Œæ„Ÿå…´è¶£çš„å¯ä»¥çœ‹åŸç‰ˆæˆ–è€…ç”¨ç¿»è¯‘è½¯ä»¶æ¥çœ‹[doge]ç½‘å€ï¼šç½‘é¡µé“¾æ¥ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-onxdcfcw1/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted --> ä¸»åŒ…æ¥å—äº†ã€Šsixth toneï¼ˆç¬¬å…­å£°ï¼‰ã€‹çš„é‡‡è®¿ï¼Œæ„Ÿå…´è¶£çš„å¯ä»¥çœ‹åŸç‰ˆæˆ–è€…ç”¨ç¿»è¯‘è½¯ä»¶æ¥çœ‹<!-- raw HTML omitted -->&lt;img alt=&quot;[doge]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/others/d_doge-be7f768d78.png%22">https://h5.sinaimg.cn/m/emoticon/icon/others/d_doge-be7f768d78.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OnZ5PAitH">æ£‹æ‰‹æˆ˜é¹° ä¸æ•Œï¼ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-onz5paith/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted --> ä¸æ•Œï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OnZdagEzg">è¯·çœ‹ä»¥ä¸‹å›¾ç‰‡ï¼Œè¯·å›ç­”ï¼šè¿™æ£‹è°èµ¢äº†ã€‚A.å·¦è¾¹é‚£ä¸ªæˆ´çœ¼é•œçš„B.å³è¾¹é‚£ä¸ªç¬‘å˜»å˜»çš„#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-onzdagezg/">
    
    
    
    
    
      
    
    è¯·çœ‹ä»¥ä¸‹å›¾ç‰‡ï¼Œè¯·å›ç­”ï¼š<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™æ£‹è°èµ¢äº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->A.å·¦è¾¹é‚£ä¸ªæˆ´çœ¼é•œçš„<!-- raw HTML omitted -->B.å³è¾¹é‚£ä¸ªç¬‘å˜»å˜»çš„<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OnZqIjsND">æ—¥æœ¬æ£‹é™¢100å‘¨å¹´åº†å…¸ï¼Œè‚å«å¹³ã€å¸¸æ˜Šã€æ›¹è–°é“‰ã€æ¢å®°è±ªå‡ºå¸­#å›´æ£‹#å›´æ£‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-onzqijsnd/">
    
    
    
    
    
      
    
    æ—¥æœ¬æ£‹é™¢100å‘¨å¹´åº†å…¸ï¼Œè‚å«å¹³ã€å¸¸æ˜Šã€æ›¹è–°é“‰ã€æ¢å®°è±ªå‡ºå¸­<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oo1QV4jGX">ä¹…ä¿å²ç»ªé‡Œ via.ä¹ƒæœ¨å‚46 &amp;NOGI46ann X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oo1qv4jgx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.ä¹ƒæœ¨å‚46 &amp;NOGI46ann X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006">https://tvax1.sinaimg.cn/large/006</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oo1R800wE">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ç¨å25:00ï½ï¼ˆJSTï¼‰æ—¥æœ¬æ”¾é€ã€ä¹ƒæœ¨å‚46çš„ANNã€è¯·ä¸€å®šè¦å¬â€¦â˜ºï¸ãƒŠã‚¤ãƒŠã‚¤æ¡‘è¾›è‹¦äº†â€¦ï¼âœ¨ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oo1r800we/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Oo2dLbTgb">ä¹…ä¿å²ç»ªé‡Œ via.NOGI46ann Xã€Œæ£’çƒå°‘å¥³@ comic é¹«å°¾å¸Œæœ›ä¿æŒä¹å¤©ã€çš„å•è¡Œæœ¬æ¼«ç”»ç¬¬ä¸€å·å†³å®šå°†äº9æœˆ25æ—¥å‘å”® [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oo2dlbtgb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.NOGI46ann X<!-- raw HTML omitted -->ã€Œæ£’çƒå°‘å¥³@ comic é¹«å°¾å¸Œæœ›ä¿æŒä¹å¤©ã€çš„å•è¡Œæœ¬æ¼«ç”»ç¬¬ä¸€å·å†³å®šå°†äº9æœˆ25æ—¥å‘å”® &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hrri5b0u9kj30xq1bsn5p.jpg%22">https://tvax4.sinaimg.cn/large/006z6nxLgy1hrri5b0u9kj30xq1bsn5p.jpg&quot;</a> referrerpolicy=&ldquo;no-referrer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OnZ8R9dLn">æŸ¯æ´#å†œå¿ƒæ¯é€‰æ‹”èµ›##èµ›æœå‘å¸ƒ# æŸ¯æ´ä¹æ®µæ‰§é»‘231æ‰‹ä¸­ç›˜èƒœè¾œæ¢“è±ªä¹æ®µã€‚æ­å–œæŸ¯æŸ¯è¿›å…¥ç¬¬26å±Šå†œå¿ƒè¾›æ‹‰é¢æ¯ä¸–ç•Œå›´æ£‹å›¢ä½“é”¦æ ‡èµ›ä¸­å›½é˜Ÿé˜µå®¹ï¼[é¼“æŒ][é¼“æŒ][é¼“æŒ] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-onz8r9dln/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%86%9C%E5%BF%83%E6%9D%AF%E9%80%89%E6%8B%94%E8%B5%9B%23&amp;amp;extparam=%23%E5%86%9C%E5%BF%83%E6%9D%AF%E9%80%89%E6%8B%94%E8%B5%9B%23%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E5%86%9C%E5%BF%83%E6%9D%AF%E9%80%89%E6%8B%94%E8%B5%9B%23&amp;amp;extparam=%23%E5%86%9C%E5%BF%83%E6%9D%AF%E9%80%89%E6%8B%94%E8%B5%9B%23&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV11T421r7fD">ã€å¼ æ·æ‚è°ˆã€‘å¾®è½¯é€€å‡ºè‘£äº‹ä¼šå°±çœŸçš„æ²¡æœ‰æ§åˆ¶OpenAIï¼Ÿ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv11t421r7fd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV17y411B77H">ã€å¼ æ·èŠç§‘æŠ€ã€‘æ— äººå‡ºç§Ÿçš„è¿è¥èƒŒåæ— äººé©¾é©¶çš„å†·æš–ä¸ç°å®</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv17y411b77h/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1KW421d7Yu">æ¸…å®®ç²å’Œ4æœŸç”Ÿ | å¤ä¹‹å¤œ | æµ´è¡£ã€æ¸¸æˆã€èŠå¤©</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1kw421d7yu/">
    
    
    
    
    
      
    
    æ¸…å®®ç²å’Œ4æœŸç”Ÿ | å¤ä¹‹å¤œ | æµ´è¡£ã€æ¸¸æˆã€èŠå¤©<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1MM4m127Nb">é™ˆç¿”å…­ç‚¹åŠï¼šæˆ‘ä¸å…„å¼Ÿå¿ƒè¿å¿ƒï¼Œå…„å¼Ÿå’Œæˆ‘ç©è„‘ç­‹</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1mm4m127nb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1t1421b7H6">ã€å¼ æ·è´¢ç»ã€‘é™©èµ„æˆä¸ºæ”¶ç§Ÿè€…ä¸å•†ä¸šåœ°äº§èµ°å‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1t1421b7h6/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1xm421g7Vt">èµ–æ¸…å¾·3å¥å°ç‹¬å˜´è„¸ï¼ŒæŠŠé€åˆ†é¢˜å˜é€å‘½é¢˜ï¼100%å°æ¹¾äººå€’äº†å¤§éœ‰</a></h1>
  <div class="date-author">
    
    <span class="date">2024-07-17</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1xm421g7vt/">
    
    
    
    
    
      
    
    ä¸€ä¸ªæ”¯æŒç‡ä¸‰æˆä¸åˆ°çš„é¢†å¯¼äººï¼Œè¯´å‡ºæ¥çš„æ¯ä¸€å¥è¯éƒ½è®©100%çš„å°æ¹¾äººå€’äº†å¤§éœ‰<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

